HEADER TRANSFERASE 18-AUG-09 2WQB TITLE STRUCTURE OF THE TIE2 KINASE DOMAIN IN COMPLEX WITH A TITLE 2 THIAZOLOPYRIMIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOPOIETIN-1 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 802-1124; COMPND 5 SYNONYM: TYROSINE-PROTEIN KINASE RECEPTOR TIE-2, TIE2 KINASE, COMPND 6 TYROSINE-PROTEIN KINASE RECEPTOR TEK, TUNICA INTERNA ENDOTHELIAL CELL COMPND 7 KINASE, P140 TEK, HTIE2; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS PHOSPHOPROTEIN, KINASE, RECEPTOR, ONCOLOGY, ATP-BINDING, TRANSFERASE, KEYWDS 2 GLYCOPROTEIN, TYROSINE-PROTEIN KINASE, PHOSPHOTRANSFERASE, KEYWDS 3 NUCLEOTIDE-BINDING, DISEASE MUTATION, THIAZOLOPYRIMIDINE EXPDTA X-RAY DIFFRACTION AUTHOR C.BRASSINGTON,J.BREED,D.BUTTAR,M.FITZEK,C.FORDER,L.HASSALL, AUTHOR 2 B.R.HAYTER,C.D.JONES,R.W.A.LUKE,E.MCCALL,W.MCCOULL,R.NORMAN, AUTHOR 3 D.PATERSON,H.MCMIKEN,S.ROWSELL,J.A.TUCKER REVDAT 6 20-DEC-23 2WQB 1 REMARK REVDAT 5 06-MAR-19 2WQB 1 REMARK REVDAT 4 17-APR-13 2WQB 1 REMARK REVDAT 3 13-JUL-11 2WQB 1 VERSN REVDAT 2 10-NOV-09 2WQB 1 JRNL REVDAT 1 03-NOV-09 2WQB 0 JRNL AUTH R.W.LUKE,P.BALLARD,D.BUTTAR,L.CAMPBELL,J.CURWEN,S.C.EMERY, JRNL AUTH 2 A.M.GRIFFEN,L.HASSALL,B.R.HAYTER,C.D.JONES,W.MCCOULL, JRNL AUTH 3 M.MELLOR,M.L.SWAIN,J.A.TUCKER JRNL TITL NOVEL THIENOPYRIMIDINE AND THIAZOLOPYRIMIDINE KINASE JRNL TITL 2 INHIBITORS WITH ACTIVITY AGAINST TIE-2 IN VITRO AND IN VIVO. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 6670 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19854647 JRNL DOI 10.1016/J.BMCL.2009.10.001 REMARK 2 REMARK 2 RESOLUTION. 2.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0088 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 8822 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 445 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.03 REMARK 3 REFLECTION IN BIN (WORKING SET) : 638 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.26 REMARK 3 BIN R VALUE (WORKING SET) : 0.2170 REMARK 3 BIN FREE R VALUE SET COUNT : 19 REMARK 3 BIN FREE R VALUE : 0.3820 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2286 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 19 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 45.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.36 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.75000 REMARK 3 B22 (A**2) : -2.84000 REMARK 3 B33 (A**2) : 6.59000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.404 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.293 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 32.445 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.910 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2367 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1599 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3207 ; 1.494 ; 1.954 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3871 ; 0.926 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 285 ; 6.401 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 108 ;37.080 ;23.426 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 392 ;21.820 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;15.705 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 347 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2657 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 506 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1432 ; 0.771 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 586 ; 0.096 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2285 ; 1.456 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 935 ; 1.726 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 922 ; 2.960 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 816 A 1120 REMARK 3 ORIGIN FOR THE GROUP (A): 39.2386 35.5125 48.9909 REMARK 3 T TENSOR REMARK 3 T11: 0.0632 T22: 0.0729 REMARK 3 T33: 0.0383 T12: 0.0206 REMARK 3 T13: 0.0191 T23: -0.0107 REMARK 3 L TENSOR REMARK 3 L11: 0.6862 L22: 1.5581 REMARK 3 L33: 0.7759 L12: 0.0482 REMARK 3 L13: -0.1069 L23: -0.2535 REMARK 3 S TENSOR REMARK 3 S11: -0.0202 S12: 0.0699 S13: -0.0980 REMARK 3 S21: -0.0508 S22: 0.0157 S23: 0.0274 REMARK 3 S31: 0.0110 S32: -0.1188 S33: 0.0045 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY REMARK 4 REMARK 4 2WQB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-AUG-09. REMARK 100 THE DEPOSITION ID IS D_1290040793. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.975 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9451 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.950 REMARK 200 RESOLUTION RANGE LOW (A) : 32.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.780 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FVR REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5 MG/ML PROTEIN, 5% (W/V) PEG6000, 5% REMARK 280 (V/V) MPD, 100MM MOPS PH7.5, 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.78650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.78650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 40.08200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.39550 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 40.08200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.39550 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 50.78650 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 40.08200 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 54.39550 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 50.78650 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 40.08200 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 54.39550 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2010 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASP 964 TO ASN REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 801 REMARK 465 ALA A 802 REMARK 465 LEU A 803 REMARK 465 ASN A 804 REMARK 465 ARG A 805 REMARK 465 LYS A 806 REMARK 465 VAL A 807 REMARK 465 LYS A 808 REMARK 465 ASN A 809 REMARK 465 ASN A 810 REMARK 465 PRO A 811 REMARK 465 ASP A 812 REMARK 465 PRO A 813 REMARK 465 THR A 814 REMARK 465 ILE A 815 REMARK 465 ASN A 834 REMARK 465 PHE A 835 REMARK 465 TYR A 860 REMARK 465 ALA A 861 REMARK 465 SER A 862 REMARK 465 LYS A 863 REMARK 465 ASP A 864 REMARK 465 ASP A 865 REMARK 465 HIS A 866 REMARK 465 ARG A 867 REMARK 465 ASP A 868 REMARK 465 PHE A 869 REMARK 465 ALA A 870 REMARK 465 GLY A 871 REMARK 465 GLU A 872 REMARK 465 MET A 997 REMARK 465 GLU A 1121 REMARK 465 GLU A 1122 REMARK 465 ALA A 1123 REMARK 465 ALA A 1124 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 825 CG CD CE NZ REMARK 470 LYS A 858 CG CD CE NZ REMARK 470 GLU A 859 CG CD OE1 OE2 REMARK 470 LEU A 873 CG CD1 CD2 REMARK 470 GLU A 874 CG CD OE1 OE2 REMARK 470 LEU A 876 CG CD1 CD2 REMARK 470 GLU A 893 CG CD OE1 OE2 REMARK 470 LYS A 995 CG CD CE NZ REMARK 470 THR A 996 OG1 CG2 REMARK 470 ARG A1099 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 817 -166.45 -70.85 REMARK 500 GLU A 832 -55.88 -142.98 REMARK 500 CYS A 877 13.98 -67.66 REMARK 500 LEU A 879 -75.70 77.76 REMARK 500 ILE A 886 113.62 -36.42 REMARK 500 ARG A 895 62.50 38.34 REMARK 500 ARG A 918 90.15 -69.53 REMARK 500 ASP A 923 67.54 -165.97 REMARK 500 ASN A 964 28.38 -142.32 REMARK 500 TYR A1108 -126.33 49.87 REMARK 500 ASP A1117 -103.34 -40.88 REMARK 500 CYS A1118 171.05 49.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE QQ1 A 2121 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2GY5 RELATED DB: PDB REMARK 900 TIE2 LIGAND-BINDING DOMAIN CRYSTAL STRUCTURE REMARK 900 RELATED ID: 1FVR RELATED DB: PDB REMARK 900 TIE2 KINASE DOMAIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 MUTATION AT D964N TO RENDER EXPRESSED PROTEIN KINASE DEAD. REMARK 999 ADDITIONAL G AT N-TERMINUS FROM CLONING. DBREF 2WQB A 801 801 PDB 2WQB 2WQB 801 801 DBREF 2WQB A 802 1124 UNP Q02763 TIE2_HUMAN 802 1124 SEQADV 2WQB ASN A 964 UNP Q02763 ASP 964 ENGINEERED MUTATION SEQRES 1 A 324 GLY ALA LEU ASN ARG LYS VAL LYS ASN ASN PRO ASP PRO SEQRES 2 A 324 THR ILE TYR PRO VAL LEU ASP TRP ASN ASP ILE LYS PHE SEQRES 3 A 324 GLN ASP VAL ILE GLY GLU GLY ASN PHE GLY GLN VAL LEU SEQRES 4 A 324 LYS ALA ARG ILE LYS LYS ASP GLY LEU ARG MET ASP ALA SEQRES 5 A 324 ALA ILE LYS ARG MET LYS GLU TYR ALA SER LYS ASP ASP SEQRES 6 A 324 HIS ARG ASP PHE ALA GLY GLU LEU GLU VAL LEU CYS LYS SEQRES 7 A 324 LEU GLY HIS HIS PRO ASN ILE ILE ASN LEU LEU GLY ALA SEQRES 8 A 324 CYS GLU HIS ARG GLY TYR LEU TYR LEU ALA ILE GLU TYR SEQRES 9 A 324 ALA PRO HIS GLY ASN LEU LEU ASP PHE LEU ARG LYS SER SEQRES 10 A 324 ARG VAL LEU GLU THR ASP PRO ALA PHE ALA ILE ALA ASN SEQRES 11 A 324 SER THR ALA SER THR LEU SER SER GLN GLN LEU LEU HIS SEQRES 12 A 324 PHE ALA ALA ASP VAL ALA ARG GLY MET ASP TYR LEU SER SEQRES 13 A 324 GLN LYS GLN PHE ILE HIS ARG ASN LEU ALA ALA ARG ASN SEQRES 14 A 324 ILE LEU VAL GLY GLU ASN TYR VAL ALA LYS ILE ALA ASP SEQRES 15 A 324 PHE GLY LEU SER ARG GLY GLN GLU VAL TYR VAL LYS LYS SEQRES 16 A 324 THR MET GLY ARG LEU PRO VAL ARG TRP MET ALA ILE GLU SEQRES 17 A 324 SER LEU ASN TYR SER VAL TYR THR THR ASN SER ASP VAL SEQRES 18 A 324 TRP SER TYR GLY VAL LEU LEU TRP GLU ILE VAL SER LEU SEQRES 19 A 324 GLY GLY THR PRO TYR CYS GLY MET THR CYS ALA GLU LEU SEQRES 20 A 324 TYR GLU LYS LEU PRO GLN GLY TYR ARG LEU GLU LYS PRO SEQRES 21 A 324 LEU ASN CYS ASP ASP GLU VAL TYR ASP LEU MET ARG GLN SEQRES 22 A 324 CYS TRP ARG GLU LYS PRO TYR GLU ARG PRO SER PHE ALA SEQRES 23 A 324 GLN ILE LEU VAL SER LEU ASN ARG MET LEU GLU GLU ARG SEQRES 24 A 324 LYS THR TYR VAL ASN THR THR LEU TYR GLU LYS PHE THR SEQRES 25 A 324 TYR ALA GLY ILE ASP CYS SER ALA GLU GLU ALA ALA HET QQ1 A2121 28 HETNAM QQ1 2-[3-(CYCLOHEXYLMETHYL)-5-PHENYL-IMIDAZOL-4-YL]-[1, HETNAM 2 QQ1 3]THIAZOLO[4,5-E]PYRIMIDIN-7-AMINE FORMUL 2 QQ1 C21 H22 N6 S FORMUL 3 HOH *19(H2 O) HELIX 1 1 ASP A 820 ILE A 824 5 5 HELIX 2 2 ASN A 909 SER A 917 1 9 HELIX 3 3 ARG A 918 ASP A 923 1 6 HELIX 4 4 ASP A 923 ASN A 930 1 8 HELIX 5 5 SER A 937 ARG A 950 1 14 HELIX 6 6 MET A 952 GLN A 957 1 6 HELIX 7 7 ALA A 966 ARG A 968 5 3 HELIX 8 8 PRO A 1001 MET A 1005 5 5 HELIX 9 9 ALA A 1006 SER A 1013 1 8 HELIX 10 10 THR A 1016 TYR A 1024 1 9 HELIX 11 11 VAL A 1026 SER A 1033 1 8 HELIX 12 12 THR A 1043 LEU A 1051 1 9 HELIX 13 13 ASP A 1064 TRP A 1075 1 12 HELIX 14 14 LYS A 1078 ARG A 1082 5 5 HELIX 15 15 SER A 1084 GLU A 1098 1 15 SHEET 1 AA 5 LYS A 825 VAL A 829 0 SHEET 2 AA 5 VAL A 838 LYS A 844 -1 O LYS A 840 N GLN A 827 SHEET 3 AA 5 ARG A 849 MET A 857 -1 O MET A 850 N ILE A 843 SHEET 4 AA 5 LEU A 898 GLU A 903 -1 O LEU A 898 N MET A 857 SHEET 5 AA 5 CYS A 892 GLU A 893 -1 O CYS A 892 N TYR A 899 SHEET 1 AB 2 ILE A 970 LEU A 971 0 SHEET 2 AB 2 LYS A 979 ILE A 980 -1 O LYS A 979 N LEU A 971 SHEET 1 AC 2 VAL A 991 TYR A 992 0 SHEET 2 AC 2 VAL A1014 TYR A1015 -1 O TYR A1015 N VAL A 991 SSBOND 1 CYS A 1040 CYS A 1118 1555 1555 2.01 CISPEP 1 TYR A 816 PRO A 817 0 -15.69 CISPEP 2 LYS A 878 LEU A 879 0 -15.48 SITE 1 AC1 9 ALA A 853 LYS A 855 LEU A 900 ILE A 902 SITE 2 AC1 9 GLU A 903 TYR A 904 ALA A 905 ARG A 968 SITE 3 AC1 9 ASN A 969 CRYST1 80.164 108.791 101.573 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012474 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009192 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009845 0.00000